Improving HIV prevention for Black cisgender women through better access to PrEP.

RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation

NIH-funded research Lurie Children's Hospital of Chicago · NIH-10916157

This study is all about helping Black women in the U.S. learn more about and access PrEP, a medication that can prevent HIV, by finding better ways to spread awareness and support so they can stay healthy and protected.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionLurie Children's Hospital of Chicago NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-10916157 on NIH RePORTER

What this research studies

This research focuses on addressing the significant disparities in the use of pre-exposure prophylaxis (PrEP) for HIV prevention among Black cisgender women in the U.S. The project aims to identify and implement effective strategies to increase PrEP awareness, access, and persistence among this population. By utilizing a combination of education, provider training, and innovative tools, the research seeks to enhance the PrEP care continuum and ensure that women at highest risk receive the support they need. The study will take place across six counties in the U.S., employing implementation science methods to evaluate the effectiveness of these strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are Black cisgender women who are at high risk for HIV and may benefit from PrEP.

Not a fit: Patients who are not at risk for HIV or who do not identify as Black cisgender women may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly increase PrEP uptake and reduce HIV transmission rates among Black cisgender women.

How similar studies have performed: While there has been success in increasing PrEP use among men and transgender women, this research focuses on a less explored area, making it a novel approach.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.